rose-walk-and-talk:-what-is-the-gleason-score-and-how-does-it-affect-prostate-cancer-treatment?

In the most recent “Rose Walk and Talk,” Yale urologist Michael Leapman discusses how the “Gleason score” aids physicians in evaluating the outlook for men with prostate cancer—allowing them to develop personalized treatment strategies.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This